Vivalyx
Vivalyx is a biotech company developing a preservation liquid, Vivalyx Omnisol, for optimal organ preservation before transplant. Their patented solution aims to make body-temperature perfusion scalable, improving organ viability and reducing transplantation risks. Vivalyx Omnisol is designed for all perfusion methods and static cold storage, offering significant cost reductions compared to blood-based alternatives.
Buy Funded Startups lists
Funding Round: Seed
Funding Amount: €5.4M
Date: 30-Apr-2024
Investors: TVF
Markets: Biotech, Healthtech
HQ: Aachen, Nordrhein-Westfalen, Germany
Founded: 2022
Website: https://vivalyx.com/
LinkedIn: https://www.linkedin.com/company/vivalyx
Crunchbase: https://www.crunchbase.com/organization/vivalyx
Leave a Comment
Comments
No comments yet.